O que há de novo na amiloidose cardíaca?

Quagliato, Priscila Cestari; Segundo Neto, Elry M. Vieirra; Assef, Jorge Eduardo; Barretto, Rodrigo B. de Mattos; Correia, Edilaide de Barros; Savioli Neto, Felício; Lin-Wang, Hui Tzu; Hirata, Mario Hiroyuki; Smanio, Paola Emanuela Poggio.
ABC., imagem cardiovasc ; 31(3)jul.-set. 2018. ilus
Artigo em Português | LILACS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-909455

Documentos relacionados

  1. Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.
  2. Myocardial perfusion in cardiac amyloidosis.
  3. Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
  4. Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review.
  5. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
  6. Evolutive echocardiographic changes in cardiac amyloidosis: Look at the whole picture.
  7. (Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis.
  8. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.
  9. Alterations in regional myocardial deformation assessed by strain imaging in cardiac amyloidosis.
  10. When and how do patients with cardiac amyloidosis die?